You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Acarbose - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for acarbose and what is the scope of patent protection?

Acarbose is the generic ingredient in two branded drugs marketed by Avet Lifesciences, Dash Pharms, Hangzhou Zhongmei, Hikma, Impax Labs, Strides Pharma, Virtus Pharm, Watson Labs, and Bayer Hlthcare, and is included in nine NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for acarbose. Eleven suppliers are listed for this compound.

Drug Prices for acarbose

See drug prices for acarbose

Recent Clinical Trials for acarbose

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of ZambiaPhase 3
University Teaching Hospital, Lusaka, ZambiaPhase 3
University of Alabama at BirminghamPhase 2

See all acarbose clinical trials

Pharmacology for acarbose
Medical Subject Heading (MeSH) Categories for acarbose
Paragraph IV (Patent) Challenges for ACARBOSE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
PRECOSE Tablets acarbose 25 mg, 50 mg and 100 mg 020482 1 2005-03-22

US Patents and Regulatory Information for acarbose

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Impax Labs ACARBOSE acarbose TABLET;ORAL 078441-002 May 14, 2009 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Virtus Pharm ACARBOSE acarbose TABLET;ORAL 091343-001 Oct 17, 2013 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Bayer Hlthcare PRECOSE acarbose TABLET;ORAL 020482-002 Sep 6, 1995 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for acarbose

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bayer Hlthcare PRECOSE acarbose TABLET;ORAL 020482-004 May 29, 1997 ⤷  Try a Trial ⤷  Try a Trial
Bayer Hlthcare PRECOSE acarbose TABLET;ORAL 020482-001 Sep 6, 1995 ⤷  Try a Trial ⤷  Try a Trial
Bayer Hlthcare PRECOSE acarbose TABLET;ORAL 020482-002 Sep 6, 1995 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.